Cassava Sciences | PTIE - Net Income

Stock Price
1.80
Daily Change
-0.11 -5.76%
Monthly
-17.05%
Yearly
-33.82%
Q1 Forecast
1.93

Cassava Sciences reported $-12.54M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
Cara Therapeutics USD -4.91M 2.77M Mar/2025
Cassava Sciences USD -12.54M 1.73M Dec/2025
Eisai JPY 17.18B 7.02B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Geron USD -31.14M 12.72M Dec/2025
J&J USD 5.12B 36M Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Novartis USD 3.93B 96M Sep/2025
Novavax USD 17.53M 219.91M Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025